Endoplasmic reticulum aminopeptidase 2 regulates CD4+ T cells pyroptosis in rheumatoid arthritis
Arthritis Research & Therapy · 2024
DOI: 10.1186/s13075-024-03271-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Research & Therapy, 2024. Verfasst von Jianhua Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Pyroptosis, Arthritis, Rheumatoid. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Rheumatoid arthritis (RA) is a chronic, progressive autoimmune disease with a complex pathogenesis that has not yet been fully elucidated, and T-cell pyroptosis is an important pathogenetic factor in RA. This study aimed to investigate the role of endoplasmic reticulum aminopeptidase 2 (ERAP2) in the pyroptosis of CD4 + T cells in RA and the specific molecular mechanism.
Methods
Peripheral venous blood was collected from human subjects, and CD4 + T cells were isolated and activated to measure the level of pyroptosis and ERAP2 expression. Pyroptosis levels were assessed using immunofluorescence, flow cytometry, qRT-PCR, and Western blotting. Changes in pyroptosis levels were observed upon knockdown or overexpression of ERAP2. To detect activated Caspase-1 in tissues, chimeric mice were engrafted with human synovial tissue and reconstituted with human CD4 + T cells. CD4 + T cells were treated with GLI1 antagonists and SMO receptor agonists to detect changes in pyroptosis levels.
Results
CD4 + T cell levels undergoing pyroptosis were found to be elevated in the blood and synovium of RA patients. The gene and protein expression of ERAP2 were significantly higher in CD4 + T cells from RA patients. Deletion of ERAP2 suppressed pyroptosis of these cells, attenuated the activation of Caspase-1 in tissue T cells, and reduced tissue inflammatory responses. Reciprocally, overexpression of ERAP2 triggered inflammasome assembly, activated Caspase-1, and induced pyroptosis in CD4 + T cells. Mechanistically, ERAP2 inhibits the Hedgehog signaling pathway and upregulates the expression of nucleotide-binding oligomerization segment-like receptor family 3(NLRP3), cleaved Caspase-1, and Gasdermin D to promote pyroptosis in CD4 + T cells.
Conclusions
Taken together, our results identify a novel mechanism by which ERAP2 regulates RA development and document the effect of the ERAP2/Hedgehog signaling axis on pyroptosis of CD4 + T cells from RA patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
- Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. chenminhao_nt@126.com.
- Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. xuhua1981111@126.com.
- Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. wangyouhua99@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Cai, H., Sun, W., Wu, W., Nan, Y., Ni, Y., Wu, X., Chen, M., Xu, H., & Wang, Y. (2024). Endoplasmic reticulum aminopeptidase 2 regulates CD4+ T cells pyroptosis in rheumatoid arthritis. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-024-03271-3
Vancouver
Zhang J, Cai H, Sun W, Wu W, Nan Y, Ni Y, et al. Endoplasmic reticulum aminopeptidase 2 regulates CD4+ T cells pyroptosis in rheumatoid arthritis. Arthritis Research & Therapy. 2024. doi:10.1186/s13075-024-03271-3
BibTeX
@article{Zhang2024,
author = {Zhang, Jianhua and Cai, Hao and Sun, Weiwei and Wu, Weijie and Nan, Yunyi and Ni, Yingchen and Wu, Xinyuan and Chen, Minhao and Xu, Hua and Wang, Youhua},
title = {Endoplasmic reticulum aminopeptidase 2 regulates CD4+ T cells pyroptosis in rheumatoid arthritis},
journal = {Arthritis Research & Therapy},
year = {2024},
doi = {10.1186/s13075-024-03271-3}
}
EUVIMED